ASX/CYV (ASX/CYV)

Australian Securities Exchange: ASX/CYV · AUD

A$0.01

+0.00 (0.0%)· Recorded snapshot

Market cap	13.7M
Revenue (ttm)	1K
Net income (ttm)	330.4M
EPS (ttm)	A$0.24
Shares out	1.4B
P/E (trailing)	0.0x
Volume	3,988
Beta	1.48

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1K
Net income (ttm): 330.4M
EPS (ttm): A$0.24
P/E (trailing): 0.0x
Market cap: 13.7M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/En/a

P25 14.6P50 21P75 31.9

Trailing P/E0

P25 15.4P50 29.4P75 64.4

ROEn/a

P25 -108P50 -50.6P75 1.1

ROIC-15

P25 -64.5P50 -33.5P75 0.8

Benchmarks · 1M

All ASX/CYV indicators

Market & fundamental data

Available fields

151

Groups with data

Currency

AUD

Showing 151 of 151 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-11-26
Employees	33
Employees change	9
Employees growth	37.5%
Enterprise value	AUD -16.3M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-07-12
Fiscal year end	June
Founded	1984
Industry	Biotechnology
Is primary listing	Yes
ISIN number	AU0000478117
Last refreshed	2026-10-30
Market cap	AUD 13.7M
Next earnings date	2026-11-26
Price	AUD 0.01
Price currency	AUD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-30
Symbol	asx/CYV
Website	https://ceryvyn.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	2,447.81%
FCF / EV yield	76.48%
FCF yield	-91.36%
Graham number	0.34529
Graham upside	3,352.9%
Industry forward P/E	28.82x
P/B ratio	0.46x
P/E ratio	0.04x
P/S ratio	13,679.78x
Price / tangible book value	0.46x
Sector forward P/E	34.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Operating margin	-1,194,700%
Pretax margin	33,023,600%
Profit margin	33,044,500%
Profit per employee	AUD 10M
Revenue per employee	AUD 30.3
ROA	-12.59%
ROA (5Y)	-71.13%
ROCE	-40.34%
ROIC	-14.98%
SBC / revenue	161,000%
Tax / revenue	-20,900%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Gross profit growth	-99.56%
Gross profit growth 3Y	-88%
Revenue growth	-99.56%
Revenue growth 10Y	-44.13%
Revenue growth 3Y	-88%
Revenue growth 5Y	-62.08%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	AUD 10,000
EBIT	AUD -11.9M
EBITDA	AUD -11.9M
EPS	AUD 0.24
FCF per share	AUD -0.01
Financing cash flow	AUD -30.9M
Free cash flow	AUD -12.5M
Free cash flow minus SBC	AUD -14.1M
Gross profit	AUD 1,000
Income taxes	AUD -209,000
Net borrowing	AUD -30.9M
Net cash flow	AUD -43.9M
Net income	AUD 330.4M
Operating cash flow minus SBC	AUD -14.1M
Operating income	AUD -11.9M
Revenue	AUD 1,000
Stock-based compensation	AUD 1.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-28.41
Book value per share	AUD 0.02
Debt / equity	0
Interest coverage	-1.08
Long-term assets	AUD 0
Long-term liabilities	AUD 0
Net cash (debt)	AUD 30M
Net cash / market cap	219.46%
Net debt / equity	-1.01
Piotroski F-Score	2
Shareholders' equity	AUD 29.6M
Tangible book value	AUD 29.6M
Tangible book value per share	AUD 0.02
Total assets	AUD 31.9M
Total cash	AUD 30M
Total debt	AUD 0
Total liabilities	AUD 2.3M
WACC	12.36%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0
Current assets	AUD 31.9M
Current liabilities	AUD 2.3M
Current ratio	13.78
Net working capital	AUD -406,000
Quick ratio	13.43
Working capital	AUD 29.6M
Working capital turnover	-0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-10.23%
Dividend per share	AUD 0.00
Last dividend	AUD 0.15
Shareholder yield	-10.23%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	0%
1M price change	11.11%
1M total return	11.11%
1W price change	-9.09%
1W total return	-9.09%
20-day SMA	AUD 0.01
3M price change	-16.67%
3M total return	-16.67%
50-day SMA	AUD 0.01
52-week high	AUD 0.03
52-week high date	2026-06-03
52-week low	AUD 0.01
52-week low date	2026-09-29
All-time high	AUD 0.03
All-time high date	2026-06-03
All-time low	AUD 0.01
All-time low date	2026-09-15
Average true range (ATR)	AUD 0.00
Average volume	5.2M
Beta (1Y)	0.84
Beta (2Y)	0.74
Beta (5Y)	1.48
Change from 52-week high	-60%
Change from 52-week low	25%
Change from all-time high	-60%
Change from all-time low	25%
Change from open	0%
Day's gap	0%
Dollar volume	AUD 39.88
High price	AUD 0.01
Low price	AUD 0.01
Monthly RSI	0
Open price	AUD 0.01
Previous close	AUD 0.01
Price vs 20-day SMA	-9.91%
Price vs 50-day SMA	-5.66%
Relative volume	0
RSI	43.12
Sharpe ratio	-0.6
Sortino ratio	-0.81
Volume	4K
Weekly RSI	37.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	772.1M
Shares change (QoQ)	2.71%
Shares change (YoY)	10.23%
Shares held by insiders	20.71%
Shares held by institutions	15.15%
Shares outstanding	1.4B

Deeper analysis on ASX/CYV

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/CYV report

Is a complete ASX/CYV research report available?

No complete published report is available for asx/CYV (ASX/CYV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/CYV (ASX/CYV)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/CYV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/CYV indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/CYV

Frequently asked questions